Eric Hahnen
University of Cologne · 227 works · 11,975 citations · h-index 48
Top works
- A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy
- SMN oligomerization defect correlates with spinal muscular atrophy severity
- Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
- Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials
- Association of Type and Location ofBRCA1andBRCA2Mutations With Risk of Breast and Ovarian Cancer
- Germline Mutation Status, Pathological Complete Response, and Disease-Free Survival in Triple-Negative Breast Cancer
- Cancer Risks Associated With GermlinePALB2Pathogenic Variants: An International Study of 524 Families
- Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer
- Common mutations of β-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar region
- Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses
- Small interfering RNA–mediated xCT silencing in gliomas inhibits neurodegeneration and alleviates brain edema
- Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations
- Prevalence of BRCA1/2 germline mutations in 21 401 families with breast and ovarian cancer
- BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers
- Gene panel testing of 5589 BRCA 1/2 ‐negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer
- Deep sequencing reveals increased DNA methylation in chronic rat epilepsy
- Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants.
- Spinal Muscular Atrophy: From Gene to Therapy
- Clinical spectrum of Kufor‐Rakeb syndrome in the Chilean kindred with ATP13A2 mutations
- Suberoylanilide hydroxamic acid (SAHA) has potent anti‐glioma properties in vitro, ex vivo and in vivo